Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
Times cited: 74
Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2.
Journal of the National Cancer Institute.
Times cited: 39